Vanda Pharmaceuticals | VNDA - EPS Earnings Per Share


Vanda Pharmaceuticals reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.06 0.7 Jun/2026
J&J USD 2.7 0.2 Sep/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Moderna USD -1.97 1.43 Jun/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 2.09 0.21 Jun/2026
Takeda JPY 71.65 87.21 Jun/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Veracyte USD 0.54 0.02 Jun/2026